FY26 Results: Profitability Soars & Margins Exceed Guidance
Alivus Life Sciences Ltd · ALIVUS · BSE ·
**Strong Profit Growth:** For the full year (FY26), Profit After Tax (PAT) grew 16.2% to Rs. 5,645 Mn, significantly outpacing revenue growth of 6.9%. **Margin Expansion:** Full-year EBITDA margin expanded by 360 bps to 33.6%, beating the company's guided range of 30-32%. **Busin…